1h Free Analyst Time
The Digital PCR & Real-Time PCR Market size was estimated at USD 8.24 billion in 2023, USD 8.87 billion in 2024, and is expected to grow at a CAGR of 7.98% to reach USD 14.11 billion by 2030. Speak directly to the analyst to clarify any post sales queries you may have.
Digital PCR (dPCR) and real-time PCR, often referred to as quantitative PCR (qPCR), are two pivotal techniques bodied under the broader field of polymerase chain reaction (PCR) science. Digital PCR (dPCR) is an advanced molecular biology technique for the absolute quantification of nucleic acids, which includes subdividing the sample into many individual, smaller reactions that contain either zero or one template molecule. Real-Time PCR, known as quantitative PCR (qPCR), differs from standard PCR by enabling the detection of the accumulation of amplification product reaction as it occurs in real-time. These techniques are in high demand owing to their heightened precision and sensitivity for detecting low-level pathogens and rare genetic sequences. The surge in the need for early and precise diagnosis and an uptick in genetic disorders and infectious diseases has led to the growth of the digital PCR & real-time PCR market. Further, the COVID-19 pandemic particularly highlighted the critical role of PCR-based diagnostics in managing infectious outbreaks. Despite its growth, the digital PCR & real-time PCR market contend with limitations, including the variability in the size and shape of droplets, which affect the robustness of the method and the need for specialized expertise in developing economies. However, growing investments by industry participants in R&D and the emergence of droplet digital PCR (ddPCR) technology for exquisite precision and sensitivity promise future prospects for the digital PCR & real-time PCR market growth.
Regional Insights
In the Americas, the digital PCR & real-time PCR market is showing robust growth, attributed to the region's strong biotechnology and pharmaceutical sectors, active government investments in healthcare research, and the wide adoption of technologically advanced diagnostic methods. The European market for digital PCR & real-time PCR is witnessing steady growth owing to the need for advanced capabilities to counter the increasing prevalence of infectious diseases, genetic disorders, and various types of cancer. Advanced healthcare infrastructure and significant investments in R&D activities in the biotechnology sector underpin the market expansion in the region. The growth in the Middle East and Africa is propelled by improving healthcare facilities, economic development, and increased access to innovative diagnostic technologies. The Asia-Pacific is emerging as the fastest-growing regional market for dPCR and qPCR technologies. The growth is largely fueled by the expanding biomedical industry in countries such as China, Japan, India, South Korea, and Australia. The region's large population base presents a significant demand for advanced diagnostic methods including dPCR and qPCR. Increased government expenditure on healthcare and the rising prevalence of chronic diseases are further catalyzing the market growth in the region.FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Digital PCR & Real-Time PCR Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Digital PCR & Real-Time PCR Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.Key Company Profiles
The report delves into recent significant developments in the Digital PCR & Real-Time PCR Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Inc., Agilent Technologies, Inc., Analytik Jena GmbH+Co. KG, Azure Biosystems Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biocompare by CompareNetworks, Inc., BIOMÉRIEUX S.A., Bioneer Corporation, Danaher Corporation, ELITech Group, Enzo Life Sciences, Inc., Eppendorf SE, Etcon Analytical and Environmental Systems & Services Ltd., Explorea s.r.o, F. Hoffmann-La Roche AG, Global Engage Sdn. Bhd., Hangzhou Longgene Scientific Instruments Co., Ltd., Heal Force Bio-Meditech Holdings Limited, Integrated DNA Technologies, Inc., LABGENE Scientific SA, Merck KGaA, Meridian Bioscience, Inc., Promega Corporation, QIAGEN N.V., Quidel Corporation, R-Biopharm AG, RainSure Scientific, Roche Diagnostics Corporation, Solis BioDyne OÜ, STANDARD BIOTOOLS INC., Takara Bio USA, Inc., Thermo Fisher Scientific Inc., and Zymo Research Corp.Market Segmentation & Coverage
This research report categorizes the Digital PCR & Real-Time PCR Market to forecast the revenues and analyze trends in each of the following sub-markets:- Type
- dPCR
- qPCR
- Product Type
- Instruments
- Reagents & Consumables
- Services
- Application
- Clinical Research
- Forensic Labs
- Research Institutes
- End-User
- Academic & Research Institutes
- Agriculture & Lifescience
- CROs & CDMOs
- Hospitals & Diagnostic Laboratories
- Pharmaceutical & Biopharmaceutical Companies
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
- Americas
The report offers valuable insights on the following aspects:
- Market Penetration: It presents comprehensive information on the market provided by key players.
- Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
- Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
- Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
- Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
- What is the market size and forecast of the Digital PCR & Real-Time PCR Market?
- Which products, segments, applications, and areas should one consider investing in over the forecast period in the Digital PCR & Real-Time PCR Market?
- What are the technology trends and regulatory frameworks in the Digital PCR & Real-Time PCR Market?
- What is the market share of the leading vendors in the Digital PCR & Real-Time PCR Market?
- Which modes and strategic moves are suitable for entering the Digital PCR & Real-Time PCR Market?
Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report
Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.
With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.
This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.
Table of Contents
1. Preface
2. Research Methodology
4. Market Overview
5. Market Insights
6. Digital PCR & Real-Time PCR Market, by Type
7. Digital PCR & Real-Time PCR Market, by Product Type
8. Digital PCR & Real-Time PCR Market, by Application
9. Digital PCR & Real-Time PCR Market, by End-User
10. Americas Digital PCR & Real-Time PCR Market
11. Asia-Pacific Digital PCR & Real-Time PCR Market
12. Europe, Middle East & Africa Digital PCR & Real-Time PCR Market
13. Competitive Landscape
14. Competitive Portfolio
15. Appendix
List of Figures
List of Tables
Companies Mentioned
- Abbott Laboratories, Inc.
- Agilent Technologies, Inc.
- Analytik Jena GmbH+Co. KG
- Azure Biosystems Inc.
- Becton, Dickinson and Company
- Bio-Rad Laboratories, Inc.
- Biocompare by CompareNetworks, Inc.
- BIOMÉRIEUX S.A.
- Bioneer Corporation
- Danaher Corporation
- ELITech Group
- Enzo Life Sciences, Inc.
- Eppendorf SE
- Etcon Analytical and Environmental Systems & Services Ltd.
- Explorea s.r.o
- F. Hoffmann-La Roche AG
- Global Engage Sdn. Bhd.
- Hangzhou Longgene Scientific Instruments Co., Ltd.
- Heal Force Bio-Meditech Holdings Limited
- Integrated DNA Technologies, Inc.
- LABGENE Scientific SA
- Merck KGaA
- Meridian Bioscience, Inc.
- Promega Corporation
- QIAGEN N.V.
- Quidel Corporation
- R-Biopharm AG
- RainSure Scientific
- Roche Diagnostics Corporation
- Solis BioDyne OÜ
- STANDARD BIOTOOLS INC.
- Takara Bio USA, Inc.
- Thermo Fisher Scientific Inc.
- Zymo Research Corp
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 183 |
| Published | March 2024 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 8.87 Billion |
| Forecasted Market Value ( USD | $ 14.11 Billion |
| Compound Annual Growth Rate | 7.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 34 |
